References
- [No authors listed]Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet19983529309429752815
- Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsLancet20053651687171715894097
- FergusonTWilckenNVaggRGhersiDNowakAKTaxanes for adjuvant treatment of early breast cancerCochrane Database Syst Rev20074CD00442117943815
- De LaurentiisMCancelloGD’AgostinoDTaxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trialsJ Clin Oncol200826445318165639
- HopwoodPRidolfiARussellSImpact on quality of life (QoL) of FEC-T compared with FEC or CMF: UK Taxotere as Adjuvant Chemotherapy Trial (TACT) 2-year follow-upJ Clin Oncol200826Suppl: abstr 548
- RochéHFumoleauPSpielmannMSequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 TrialJ Clin Oncol2006245664567117116941
- MartinMMackeyJVogelCBenefit from adjuvant taxanes and endocrine responsiveness in breast cancerBreast200716Suppl 2S127S13117923408
- AndreFBroglioKRocheHEstrogen receptor expression and efficacy of docetaxel containing adjuvant chemotherapy in patients with node positive breast cancer: results from a pooled analysisJ Clin Oncol2008262636264318509176
- HughJHansonJCheangMCBreast cancer subtypes and response to docetaxel in node-positive breast cancer use of an immunohistochemical definition in the BCIRG 001 TrialJ Clin Oncol2009271168117619204205
- HayesDFThorADDresslerLGCancer and Leukemia Group B (CALGB) InvestigatorsHER2 and response to paclitaxel in node-positive breast cancerN Engl J Med20073571496150617928597
- Cancer Therapy Evaluation ProgramCommon terminology criteria for adverse events 3.0 (CTCAE)2006 Available from: http://www.eortc.be/services/doc/ctc/ctcaev3.pdfAccessed February 28, 2013
- HendersonICBerryDADemetriGDImproved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancerJ Clin Oncol20032197698312637460
- MamounasEPBryantJLemberskyBPaclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from NSABP B-28J Clin Oncol2005233686369615897552
- MartinMPienkowskiTMackeyJBreast Cancer International Research Group 001 InvestigatorsAdjuvant docetaxel for node-positive breast cancerN Engl J Med20053522302231315930421
- BriaENisticoCCupponeFBenefits of taxane as adjuvant chemotherapy for early breast cancer: pooled analysis of 15,500 patientsCancer2006106112337234416649217